Dhurairaj Satheesh

Mr. Dhurairaj Satheesh

Bharathiar University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2020 in Heliyon
Verified
Journal Article
Open access
PDF file
DSDhurairaj Satheesh
Dhurairaj Satheesh
ARAnnamalai Rajendran
Annamalai Rajendran
KCKasi Chithra
Kasi Chithra
The disease called severe acute respiratory syndrome (SARS) is a lifestyle intimidating viral contamination affected by a positive, single stranded novel RNA virus (COVID-2019) from the enveloped coronaviruse family. The COVID-2019 virus has affected many people, scattering promptly, and researchers are attempting to find out medicines for its effectual cure in all over the globe. Chloroquine (ChQ) and its derivatives, an older drug used for the cure of malaria, is exposed to encompass a perceptible feasibility and commendable well-being in opposition to SARS CoV-2 associated pneumonia clinical trials conducted in China. Later on, a few investigations have been directed to find and present SARS CoV-2 antiviral medications. The aim of this present work deals with the potential binding interactions of some imidazolium salts with Nsp9 (Nonstructural protein 9) RNA binding protein of SARS CoV-2.

22 July 2022 in Journal of the Indian Chemical Society
Verified
Journal Article
Closed access
NAN. Afsar
N. Afsar
DJD. Reuben Jonathan
D. Reuben Jonathan
DSDhurairaj Satheesh
Dhurairaj Satheesh
SMS. Manivannan
S. Manivannan

18 April 2022 in Journal of the Indian Chemical Society
Verified
Journal Article
Closed access
MKM. Kaviraj
M. Kaviraj
MPM. Andrew Pradeep
M. Andrew Pradeep
DSDhurairaj Satheesh
Dhurairaj Satheesh

27 March 2025 in Journal of Ionic Liquids
Verified
Journal Article
Open access
DSDhurairaj Satheesh
Dhurairaj Satheesh
ARAnnamalai Rajendran
Annamalai Rajendran
CGChandrasekran Geetha
Chandrasekran Geetha
KPKrishnan Parthipan
Krishnan Parthipan
ATAyyandurai Thirunavukkarasu
Ayyandurai Thirunavukkarasu
KSKarunanithi Suganya
Karunanithi Suganya

12 November 2025 in Hybrid Advances
Verified
Journal Article
Open access
KJKrishnasami Jayanthi
Krishnasami Jayanthi
PPPeriasamy Pazhanisamy
Periasamy Pazhanisamy
KPKrishnan Parthipan
Krishnan Parthipan
ATAyyandurai Thirunavukkarasu
Ayyandurai Thirunavukkarasu
PKPerumal Krishnan
Perumal Krishnan
DSDhurairaj Satheesh
Dhurairaj Satheesh

13 February 2023 in Advanced Chemicobiology Research
Verified
Journal Article
Open access
PDF file
AKASHOK KAMALANATHAN
ASHOK KAMALANATHAN
MBMuthu Babu
Muthu Babu
DSDhurairaj Satheesh
Dhurairaj Satheesh
Coronavirus disease 2019 (COVID-19) has a negative effect on the poor, minority populations, and a wide variety of vulnerable communities because of its unequal distribution in populated regions and its limited ability to be mitigated by the rise in chronic conditions or the lack of access to high-quality healthcare (HC). Furthermore, the pandemic's negative consequences, such as social isolation and travel limitations, disproportionately affect persons in the poorest socioeconomic (SE) groups. We prepared seven national case studies from across the world to address the difficulties of improving health and highlight some of the responses used by government agencies and local groups: Afghanistan (AFGN), Albania (ALB), Algeria (ALGR), Australia (AU), Brazil (BR), China (CN), and France (FR). We encourage academics to continue doing rigorous research and establishing a sound evidence foundation for further scientific inquiries into COVID-19 health equity problems throughout the world. HC organisations may improve their agility, resilience, and learning with the support of insights from complexity science in order to better prepare for unexpected occurrences in the future.